Skip to main content
. 2017 Aug 12;8(45):78757–78766. doi: 10.18632/oncotarget.20225

Figure 5. Effects of ERp29 on tumor growth in vivo.

Figure 5

(A) Photographs of tumors derived from BGC-823/vector, BGC-823/ERp29, SGC-7901/ vector and SGC-7901/ ERp29 cells in nude mice. (B) and (D) Growth kinetics of tumors in nude mice. Tumor diameters were measured every 5 days during the 30 days. (C) and (E) Average weights of tumors in nude mice. Data are expressed as the mean ± SD.